Virus-like particles, methods and immunogenic compositions

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving virus or bacteriophage

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

4242081, 435348, 435 691, 435 693, 536 2372, 536 241, C12P 2106, A61K 3921, C07H 2104, C12Q 170

Patent

active

060776625

ABSTRACT:
The present disclosure provides retrovirus-like particles which comprise retrovirus env proteins, immunogenic compositions comprising retrovirus-like particles, methods for the production of retrovirus-like particles and methods for the protection of an animal or a human from retrovirus infection using the retrovirus-like particles of the present invention.

REFERENCES:
patent: 5462734 (1995-10-01), Letchworth, III et al.
patent: 5541062 (1996-07-01), Smeekens et al.
patent: 5561228 (1996-10-01), Or et al.
patent: 5562909 (1996-10-01), Allcock et al.
patent: 5562910 (1996-10-01), Daynes et al.
patent: 5571531 (1996-11-01), McDermott et al.
Yamshchikov, G.V., et al. "Assembly of SIV virus-like particles containing envelope proteins using a baculovirus expression system", (1995), Virol. 214:50-58.
Vzorov, A.N., and Compans, R.W. "Assembly and release of SIV Env proteins with full-lenght or truncated cytoplasmic domains", (1996), Virol. 221:22-33.
Luo, L., et al. "Expression of gag precursor protein and secretion of virus-like gag particles of HIV-2 from recombinant baculovirus-infected insect cells", (1990), Virol. 179:874-880.
Porter, D.C., et al. "Release of virus-like particles from cells infected with poliovirus replicons which express human immunodeficiency virus type 1 gag", (1996), J. of Virol. 70(4):2643-2649.
Morikawa, S., et al. "Analyses of the requirements for the synthesis of virus-like particles by feline immunodeficiency virus gag using baculovirus vectors", (1991), Virol. 183:288-297.
Zingler, K. and Littman, D.R. "Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein increases Env incorporation into particles and fusogenicity and infectivity", (1993), J. of Virol. 67(3):2824-2831.
Haffar, O.K., et al. "Inhibition of virus production in peripheral blood mononuclear cells from human immunodeficiency virus (HIV) type 1-seropositive donors by treatment with recombinant HIV-like particles", (1992), J. of Virol. 66(7):4279-4287.
Rovinski, B., et al. "Expression and characterization of genetically engineered human immunodeficiency virus-like particles containing modified envelope glycoproteins: Implications for development of a cross-protective AIDS vaccine", (1992), J. of Virol. 66(7):4003-4012.
Krausslich, H-G., et al. "Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase", (1993), Virol. 192:605-617.
Vzorov, A.N., et al. "Highly immunogenic human immunodeficiency viruslike particles are produced by recombinant vaccinia virus-infected cells", (1991), AIDS Res. Hum. Retr. 7(1):29-36.
Haffar, O., et al. "Human immunodeficiency virus-like, nonreplicating, gag-env particles assemble in a recombinant vaccinia virus expression system", (1990), J. of Virol. 64(6):2653-2659.
Haffar, O.K., et al. "HIV-specific humoral and cellular immunity in rabbits vaccinated with recombinant human immunodeficiency virus-like-gag-env particles", (1991), Virol. 183:487-495.
Delchambre, M., et al. "The GAG precursor of simian immunodeficiency virus assembles into virus-like particles", (1989), EMBO J. 8(9):2653-2660.
Wills, J.W. and Craven R.C. "Form, function, and use of retroviral Gag proteins", (1991), AIDS 5:639-654.
Vincent, M.J., et al. "Characterization of a novel baboon virus closely resembling human t-cell leukemia virus", (1996), Virol. 226:57-65.
Haynes, J.R., et al. "Production of immunogenic HIV-1 viruslike particles in stably engineered monkey cell lines", (1991), AIDS Res. Hum. Retr. 7(1):17-27.
Dong, J. and Hunter, E. "Analysis of retroviral assembly using a vaccinia/T7-polymerase complementation system", (1993), Virol. 194:192-199.
Ball, J.M. et al. "EIAV genomic organization: further characterization by sequencing of purified glycoproteins and cDNA," (1988), Virology, 165:601-605.
Chazal, N. et al. "Human immunodeficiency virus type 1 MA deletion mutants expressed in baculovirus-infected cells: cis and trans effects on the Gag precursor assembly pathway," (1995), J. Virol., 69:365-375.
Boomer, S. et al. "Isolation of a novel subgroup B feline leukemia virus from a cat infected with FeLV-A," (1994), Virology, 204:805-810.
Zhou, W., et al. "Identification of membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 gag protein which interacts with acidic phospholipids", (1994), J. Virol. 68:2556-2569.
Yuan, X. et al. "Mutations in the N-terminal region of human immunodeficiency virus type 1 matrix protein block intracellular transport of the Gag precursor," (1993), J. Virol., 67:6387-6394.
Yu, X., et al. "The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virus", (1992), J. Virol. 66:4966-4971.
Willey, R.L. et al. "Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160," (1988), Proc. Natl. Acad. Sci. USA, 85:9580-9584.
Wang, B. et al. "Molecular cloning, expression, and biological characterization of an HTLV-II envelope glycoprotein: HIV-1 expression is permissive for HTLV-II induced cell fusion," (1993), AIDS Res. Hum. Retroviruses, 9:849-860.
Vile, R.G., et al. "A murine cell line producing HTLV-I pseudotype virions carrying a selectable marker gene", (1991), Virol. 180:420-424.
Vey, M. et al. "Maturation of the trans-Golgi network protease furin: compartmentalization of propeptide removal, substrate cleavage, and COOH-terminal truncation," (1994), J. Cell Biol., 127:1829-1842.
Spies, C.P., et al. "Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein alters conformation of the external domain", (1994), J. Virol. 68:585-591.
Schlitz, R., et al. "Equine infectious anemia virus gene expression: characterization of the RNA splicing pattern and the protein products encoded by open reading frames S1 and S2," (1992), J. Virol., 66:3455-3465.
Rushlow, K. et al. "Lentivirus genomic organization: the complete nucleotide sequence of the env gene region of equine infectious anemia virus," (1986), Virology, 155:309-321.
Royer, M. et al. "Functional domains of HIV-1 Gag polyprotein expressed in baculovirus-infected cells," (1991), Virology, 184:417-422.
Rohn, J.L., et al. "Evolution of feline leukemia virus variant genomes with insertions, deletions, and defective envelope genes in infected cats with tumors", (1994), J. Virol. 68:2458-2467.
Ritter, D.G., et al. "Cell fusion activity of the simian immunodeficiency virus envelope protein is modulated by the intracytoplasmic domain," (1993), Virology, 197:255-264.
Pique, C. et al. "Mutations introduced along the HTLV-I envelope gene result in a non-functional protein: a basis for envelope conservation?" (1990), EMBO J., 9:4243-4248.
Pancino, G., et al. "Differences in feline immunodeficiency virus host cell range correlate with envelope fusogenic properties," (1995), Virology, 206:796-806.
Page, K.A. et al. "Analysis of mutations in the V3 domain of gp160 that affedct fusion and infectivity," (1992), J. Virol., 66:524-533.
Overton, H.A., et al. "The protease and gag gene products of the human immunodeficiency virus: authentic cleavage and post-translational modification in an insect cell expression system", (1989), Virol. 170:107-116.
Morikawa, Y. et al. "Legitimate and illegitimate cleavage of human immunodeficiency virus glycoproteins by furin," (1993), J. Virol., 67:3601-3604.
Mulligan, M.J., et al. "Cytoplasmic domain truncation enhances fusion activity by the exterior glycoprotein complex of human immunodeficiency virus type 2 in selected cell types", (1992), J. Virol. 66:3971-3975.
Moore, J., et al. "Which gp160 vaccine?", (1993), Nature 361:503.
Moldoveanu, Z., et al. "Immune Responses to influenza virus in orally and systemically immunized mice", (1989), Curr. Top. Microbiol. Immunol. 146:91-99.
McCune, J.M., et al. "Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus," (1988), Cell, 53:55-67.
Marx, P.A., et al. "Protectio

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Virus-like particles, methods and immunogenic compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Virus-like particles, methods and immunogenic compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Virus-like particles, methods and immunogenic compositions will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1850784

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.